Navigation Links
COPAN Files New Patents Following the Development of High Nucleic Acid Yield Flocked Swabs
Date:12/16/2010

MURRIETA, Calif., Dec. 16, 2010 /PRNewswire/ -- COPAN has enjoyed widespread use of its flocked swabs line, branded as FLOQSwabs, in microbiology for the collection and transportation of bacterial and viral samples.

FLOQSwabs by COPAN have been shown through numerous independent studies to collect more sample and elute the entire sample thus improving the detection and diagnosis of infectious disease agents. In spite of this success, the company has remained committed to continual innovation to optimize the sample collection, preservation and maximize the release of the target analyte into numerous assay platforms. New research at COPAN has led to an important technological breakthrough in the yield of target nucleic acid from its FLOQSwabs.  In the case of Low Copy Numbers (LCN) when minute quantities of nucleic acid might be present in a sample, maximum yield of nucleic acid can make the difference between a positive or negative result.

Even though FLOQSwabs release almost the entire sample, nucleic acid has a tendency to be sticky and some residue can still attach to swab fibers. This risk is eliminated with COPAN's latest discovery in fiber treatment for flocked swabs. COPAN's high nucleic acid yield FLOQSwabs now deliver as much as 1 log more nucleic acid, equivalent to 3 PCR cycles less for detection. This demonstrable improvement is another milestone in the evolution of flocked swab technology and ensures the maximum sensitivity of assay. The recent discoveries are now the subject of a series of new patent applications by COPAN in the USA and in other countries around the world.

Worldwide, COPAN holds numerous patents for its original line of flocked swabs, FLOQSwabs.

About Copan Group

With a reputation for innovation in preanalytics, Copan is the leading manufacturer of collection and transport systems in the world. COPAN offers a complete range of microbial sampling products used for traditional culture analysis and molecular diagnostic assays. For more information, visit www.copanusa.com


'/>"/>
SOURCE Copan Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. COPAN Secures Japanese Patent for its Flocked Swab Innovation
2. Copan Redefines Automated Specimen Processing with Groundbreaking New Features
3. Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma
4. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
5. ERT Files Shelf Registration Statement
6. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
7. Chesley Files Class Action Against DePuy Orthopaedics
8. Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
9. Peptimmune Files Citizen Petition Regarding Generic Copaxone and Demonstrates Significant Enabling Technology for Biological Characterization of Copaxone
10. Volcano Corporation Files Counterclaim Asserting St. Jude Infringes Three Volcano Patents; Answers St. Judes Patent Infringement Claims
11. China-Biotics Files New Patent Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):